APR 13, 2015 6:51 AM PDT

FDA Cites Diabetes Drug For Possible Increased Risk Of Death

WRITTEN BY: Judy O'Rourke

The agency's review of data on the drug Onglyza, from AstraZeneca, also found an increased risk of hospitalization due to heart failure. [Source: Newsy Science]
About the Author
Bachelor's (BA/BS/Other)
Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
Loading Comments...